Literature DB >> 21557696

Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered.

Ayse Nur Torun1, Mehmet Vural, Hasan Cece, Hakan Camuzcuoglu, Harun Toy, Nurten Aksoy.   

Abstract

Paraoxonase-1 (PON1) activity is decreased in polycystic ovary syndrome (PCOS) having metabolic syndrome (MetS) or insulin resistance (IR). We aimed to assess PON1 activity and oxidative stress in PCOS without MetS or IR. Metabolic and hormonal parameters, high-sensitive C-reactive protein (hs-CRP), oxidative stress parameters (total antioxidant status (TAS), total oxidative stress (TOS), oxidative stress index (OSI), lipid hydroperoxide (LOOH), total free sulfhydryl (--SH) groups), PON and arylesterase were analyzed in 30 normal weighed patients with PCOS without MetS or IR and 20 normal controls. Hs-CRP, PON, arylesterase, and TAS levels of PCOS and control groups were similar. LOOH, TOS, and OSI of PCOS group were higher than in the controls (p < 0.05; p < 0.001, and p < 0.001, respectively). - SH group levels showed a positive correlation with free testosterone (fT). TOS positively correlated with free androgen index (FAI), body mass index (BMI), waist-to-hip ratio (WHR), LOOH, and OSI. This study showed that oxidative stress is increased in PCOS even in the absence of MetS or IR. PON1 activity appears not to be affected in PCOS without MetS and IR. Several metabolic and antropometric risk factors may aggravate this altered oxidative state in PCOS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21557696     DOI: 10.3109/09513590.2011.569798

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

1.  Association of -108 C>T PON1 polymorphism with polycystic ovary syndrome.

Authors:  Polonca Ferk; Ksenija Gersak
Journal:  Biomed Rep       Date:  2013-12-30

Review 2.  Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review.

Authors:  Masoumeh Mohammadi
Journal:  Int J Prev Med       Date:  2019-05-17

Review 3.  The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Hong Gao; YanTao Li; WenNan Yan; Fei Gao
Journal:  Int J Endocrinol       Date:  2021-01-30       Impact factor: 3.257

4.  The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Authors:  Shaimaa Aboeldalyl; Cathryn James; Emaduldin Seyam; Emad Moussa Ibrahim; Hossam El-Din Shawki; Saad Amer
Journal:  Int J Mol Sci       Date:  2021-03-08       Impact factor: 5.923

5.  The effect of resveratrol on oxidative stress in the liver and serum of a rat model of polycystic ovary syndrome: An experimental study.

Authors:  Mahnaz Ghowsi; Homayoun Khazali; Sajjad Sisakhtnezhad
Journal:  Int J Reprod Biomed       Date:  2018-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.